Status:
TERMINATED
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
CytRx
Cephalon
Conditions:
Acute Promyelocytic Leukemia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Subjects have acute promyelocytic leukemia (APL) that has come back (relapsed) after initial treatment or has not gone away with initial therapy. This research study involves testing an investigationa...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Must have diagnosis of relapsed APL
- Must have completed any prior cancer treatment at least 6 months prior to study
- Must have had prior treatment that included ATRA
Exclusion
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00985530
Start Date
October 1 2009
End Date
May 1 2011
Last Update
October 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611